<?xml version="1.0" ?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:seo="http://purl.org/seo/elements/1.0/" version="2.0">
	<channel>
		<title>Nirvana Life Sciences Inc. News Releases</title>
		<link>https://feeds.newsfilecorp.com/company/5430</link>
		<description>Latest news from Nirvana Life Sciences Inc., as distributed by TMX Newsfile.</description>
		<language>en</language>
		<copyright>CopyRight (c) 2026, Newsfile Corp. All Rights Reserved.</copyright>
		<managingEditor>office@newsfilecorp.com (Newsfile Corp.)</managingEditor>
		<webMaster>office@newsfilecorp.com (Newsfile Corp.)</webMaster>
		<lastBuildDate>Tue, 10 Mar 2026 13:35:16 -0400</lastBuildDate>
		<image>
			<url>https://www.newsfilecorp.com/images/newswire/customer-logos/5430.jpg</url>
			<title>Nirvana Life Sciences Inc. News Releases</title>
			<link>https://feeds.newsfilecorp.com/company/5430</link>
		</image>
		<atom:link rel="self" type="application/rss+xml" href="https://feeds.newsfilecorp.com/company/5430"/>
		<item xml:lang="en">
			<title>Nirvana Life Sciences Inc. Announces Receipt of First North American Production of SOSA, a Patented, WHO Approved, Herbal Treatment for Opiate Addiction</title>
			<link>https://www.newsfilecorp.com/release/195855/Nirvana-Life-Sciences-Inc.-Announces-Receipt-of-First-North-American-Production-of-SOSA-a-Patented-WHO-Approved-Herbal-Treatment-for-Opiate-Addiction</link>
			<description>Vancouver, British Columbia--(Newsfile Corp. - January 29, 2024) - Nirvana Life Sciences Inc. (CSE:  NIRV) (Nirvana or the "Company"), a western Canadian-based life sciences company, is pleased to report that it has received its first shipment of "SOSA",  a leading addictions focused herbal treatment.SOSA is a patented, WHO-approved, herbal treatment for opiate addiction that has been administered to more than 30 million patients in Asia. SOSA is registered with the health authorities in China,...&lt;img src="https://api.newsfilecorp.com/newsinfo/195855/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Mon, 29 Jan 2024 09:01:00 -0500</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/195855</guid>
		</item>
		<item xml:lang="en">
			<title>Nirvana Life Sciences Inc. Announces Acquisition of Licensed Distributor of a Patented, WHO Approved, Herbal Treatment for Opiate Addiction</title>
			<link>https://www.newsfilecorp.com/release/177325/Nirvana-Life-Sciences-Inc.-Announces-Acquisition-of-Licensed-Distributor-of-a-Patented-WHO-Approved-Herbal-Treatment-for-Opiate-Addiction</link>
			<description>Vancouver, British Columbia--(Newsfile Corp. - August 15, 2023) - Nirvana Life Sciences Inc. (CSE: NIRV) (Nirvana or the " Company"), a western Canadian based life sciences company aimed at developing psychedelic and other natural based medicines, including non-addictive chronic pain and relapse preventing pharmaceutical medicines, is pleased to report that it has completed its acquisition of Medsmart Dispensary Inc, the distributor of a leading addictions focused herbal treatment.Nirvana Life...&lt;img src="https://api.newsfilecorp.com/newsinfo/177325/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Tue, 15 Aug 2023 10:53:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/177325</guid>
		</item>
		<item xml:lang="en">
			<title>Nirvana Life Sciences Inc. Announces the Acquisition of Licensed Distributor of a Patented, WHO Approved, Herbal Treatment for Opiate Addiction</title>
			<link>https://www.newsfilecorp.com/release/169083/Nirvana-Life-Sciences-Inc.-Announces-the-Acquisition-of-Licensed-Distributor-of-a-Patented-WHO-Approved-Herbal-Treatment-for-Opiate-Addiction</link>
			<description>Vancouver, British Columbia--(Newsfile Corp. - June 7, 2023) - Nirvana Life Sciences Inc. (CSE: NIRV) (Nirvana or the "Company"), a western Canadian based life sciences company aimed at developing psychedelic and other natural based medicines, including non-addictive chronic pain and relapse preventing pharmaceutical medicines, is pleased to report that it has entered into a definitive agreement for the acquisition of Medsmart Dispensary Inc., the distributor of a leading addictions focused...&lt;img src="https://api.newsfilecorp.com/newsinfo/169083/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Wed, 07 Jun 2023 09:14:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/169083</guid>
		</item>
	</channel>
</rss>
